CD90+ gastric cancer cells showed a phenotype similar to CSCs after being treated with conventional chemotherapeutics; thus, the percentage of CD90+ gastric cancer cells increased (Fu et al., 2020). This evidence concerns the gene THY1 and gastric cancer.